Clinical trial Recruiting at 1 site Observational Ages 18 and up

Optical and multi-modal analysis to help diagnose skin cancer

Official title: Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.

Run by Centre Hospitalier Régional Metz-Thionville · NCT07406022 · Data updated 2026-11-12

This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment140 (estimated)
SponsorCentre Hospitalier Régional Metz-Thionville
Academic / other
Locations1 site (Metz)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedJune 24, 2026
Trial IDNCT07406022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with skin carcinomas or actinic keratoses seeking diagnostic evaluation.

Probably not a fit

Patients without skin lesions or without diagnostic uncertainty may not benefit from this observational data collection.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The OpticSkin project collects and shares a database of histology and optical spectroscopy data from healthy, precancerous, and cancerous skin. It uses methods such as absorption, scattering (including Raman), autofluorescence, and polarization measurements to identify signatures associated with skin cancers. The study emphasizes multi-modality data integration and may involve machine learning to improve diagnostic accuracy. It is observational and aims to complement traditional histology with non-invasive diagnostic information. The work is supported by PEPR LUMA and led by CHR Metz-Thionville, focusing on real-world clinical relevance for skin cancer imaging and diagnosis.

Why it matters

Potential benefit: If successful, the approach could provide additional diagnostic clues to improve accuracy and speed in identifying skin cancer.

How similar studies have gone: Previous work suggests that combining imaging and spectroscopy can improve diagnostic information, though the exact multi-modality approach is novel in this project context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with skin carcinomas and actinic keratoses

Exclusion Criteria:

* minor patient

Where it's running

  • CHR Metz-Thionville
    Metz, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.